• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[一例隐匿性乳腺癌病例]

[A Case of Occult Breast Cancer].

作者信息

Abe Sadahiko, Abe Noriko, Noda Masaru, Okano Maiko, Tachibana Kazunoshin, Yoshida Sayaka, Kiko Yuuichirou, Hashimoto Yuko, Hatakeyama Yuuichi, Rokkaku Yuuichi, Ohtake Tohru

机构信息

Dept. of Breast Surgery, Fukushima Medical University School of Medicine.

出版信息

Gan To Kagaku Ryoho. 2017 Nov;44(12):1095-1097.

PMID:29394545
Abstract

We report a case of occult breast cancer. A 61-years-old woman underwent tumorectomy of right axillary mass. Pathological diagnosis was adenocarcinoma. Two years after, right axillary mass was discovered again. Wide local excision, axillary lymph node dissection and radiation therapy of the breast was performed. Pathological findings showed lymph node metastasis of breast cancer, or primary cancer of the axially tail of the breast. Ten months after second operation, she presented an axillary mass again. She underwent resection of the axillary tumor. The pathological findings showed lymph node metastasis of breast cancer. There was no evidence of primary tumor of the breast during the period. We suspected lymph node metastasis of occult breast cancer. Irradiation was administered to the right axilla, and she is receiving endocrine therapy.

摘要

我们报告一例隐匿性乳腺癌病例。一名61岁女性接受了右腋窝肿块肿瘤切除术。病理诊断为腺癌。两年后,右腋窝肿块再次被发现。进行了广泛局部切除、腋窝淋巴结清扫及乳房放疗。病理结果显示为乳腺癌淋巴结转移,或乳腺腋尾部原发性癌。第二次手术后十个月,她再次出现腋窝肿块。她接受了腋窝肿瘤切除术。病理结果显示为乳腺癌淋巴结转移。在此期间未发现乳腺原发性肿瘤的证据。我们怀疑为隐匿性乳腺癌淋巴结转移。对右腋窝进行了放疗,她正在接受内分泌治疗。

相似文献

1
[A Case of Occult Breast Cancer].[一例隐匿性乳腺癌病例]
Gan To Kagaku Ryoho. 2017 Nov;44(12):1095-1097.
2
[Axillary Lymph Nodes Metastases from Occult Breast Cancer Recurrence at Ten Years after Resection--Case Report].[隐匿性乳腺癌切除术后十年腋窝淋巴结转移复发——病例报告]
Gan To Kagaku Ryoho. 2015 Nov;42(12):1776-8.
3
Metachronous secondary primary occult breast cancer initially presenting with metastases to the contralateral axillary lymph nodes: report of a case.同时性双侧隐匿性乳腺癌初始表现为对侧腋窝淋巴结转移:病例报告。
Breast Cancer. 2010;17(1):71-4. doi: 10.1007/s12282-009-0097-9. Epub 2009 Mar 4.
4
[A Case of a Bulky Axillary Ectopic Breast Cancer Which Successfully Resected after Chemotherapy(Docetaxel)].[1例经化疗(多西他赛)后成功切除的巨大腋窝异位乳腺癌病例]
Gan To Kagaku Ryoho. 2018 Feb;45(2):306-308.
5
[Two cases of recurrent breast cancer with regional lymph node metastases showing a complete response to trastuzumab and paclitaxel treatment].两例复发性乳腺癌伴区域淋巴结转移对曲妥珠单抗和紫杉醇治疗显示完全缓解
Gan To Kagaku Ryoho. 2006 Sep;33(9):1301-3.
6
[Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].[早期浸润性乳腺癌前哨淋巴结活检阳性后腋窝的最佳治疗。OTOASOR试验的早期结果]
Orv Hetil. 2013 Dec 8;154(49):1934-42. doi: 10.1556/OH.2013.29765.
7
[Axillary Lymph Node Dissection and Chemotherapy were Useful for Occult Cancer - Report of a Case].[腋窝淋巴结清扫术及化疗对隐匿性癌有效——病例报告]
Gan To Kagaku Ryoho. 2016 Nov;43(12):2065-2067.
8
Factors affecting lymph node yield in patients undergoing axillary node dissection for primary breast cancer: a single-institution review.影响原发性乳腺癌腋窝淋巴结清扫术患者淋巴结检出数的因素:单中心回顾性研究。
Ann Surg Oncol. 2012 Jun;19(6):1818-24. doi: 10.1245/s10434-011-2199-9. Epub 2011 Dec 28.
9
Occult breast carcinoma presenting with axillary lymph node metastases.以腋窝淋巴结转移为表现的隐匿性乳腺癌。
Rev Invest Clin. 2002 May-Jun;54(3):204-8.
10
[Occult Breast Carcinoma and Recurrent Tumor in the Breast 14 Years after Axillary Dissection-A Case Report].[腋窝清扫术后14年隐匿性乳腺癌及乳腺复发性肿瘤——病例报告]
Gan To Kagaku Ryoho. 2019 Dec;46(13):2249-2251.

引用本文的文献

1
Occult breast cancer in an older woman: A case report.老年女性隐匿性乳腺癌:一例病例报告。
Exp Ther Med. 2024 Dec 24;29(2):38. doi: 10.3892/etm.2024.12788. eCollection 2025 Feb.